 Progyny Inc NASDAQ: PGNY reported Q2 EPS of 0.19, a turnaround from EPS loss of 0.01 a year ago, edging out analysts average expectation of 0.08. Sales almost doubled to 128.6 million but missed the consensus of 129.31 million, primarily due to increased clients and covered lives. 